Batabyal, Subrata
Gajjeraman, Sivakumar
Pradhan, Sanjay
Bhattacharya, Sulagna
Wright, Weldon
Mohanty, Samarendra https://orcid.org/0000-0002-6533-383X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (2R44EY025905-02A1, 1R01EY025717-01A1, 1R01 EY028216-01A1, 1R43EY025905, 2R44EY025905-02A1, 1R01EY025717-01A1, 1R01 EY028216-01A1)
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
Article History
Received: 14 June 2019
Revised: 11 September 2020
Accepted: 29 September 2020
First Online: 22 October 2020
Compliance with ethical standards
:
: SM and SBh have equity interest in Nanoscope Technologies, LLC, which is developing products in Biomedical diagnostics and therapeutic technologies.
: All experimental procedures were conducted according to the Nanoscope Technologies’ Institutional Animal Care and Use Committee approved protocol and standard operating procedures (SOPs).